Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 05985 combination versus its individual components and placebo in essential hypertension
ISRCTN14235381Phase 2Completed
- Sponsor
- Servier
- Start
- May 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of perindopril + indapamide + amlodipine in essential hypertension (4 arms), sponsored by Servier. Primary endpoint: Change in blood pressure. Started May 2007; status: completed.
02
Drugs
perindopril + indapamide + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ISRCTN14235381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14235381.